Treating Addictions: Harm Reduction in Clinical Care and Prevention
- 2.2k Downloads
This paper examines the role of clinical practitioners and clinical researchers internationally in establishing the utility of harm-reduction approaches to substance use. It thus illustrates the potential for clinicians to play a pivotal role in health promoting structural interventions based on harm-reduction goals and public health models. Popular media images of drug use as uniformly damaging, and abstinence as the only acceptable goal of treatment, threaten to distort clinical care away from a basis in evidence, which shows that some ways of using drugs are far more harmful than others and that punitive approaches and insistence on total abstinence as the only goal of treatment often increases the harms of drug use rather than reducing drug use. Therefore the leadership and scientific authority of clinicians who understand the health impact of harm-reduction strategies is needed. Through a review of harm-reduction interventions in Canada, the United Kingdom, the United States, Australia, Switzerland, and the Netherlands, we identify three ways that clinicians have helped to achieve a paradigm shift from punitive approaches to harm-reduction principles in clinical care and in drug policy: (1) through clinical research to provide data establishing the effectiveness and feasibility of harm-reduction approaches, (2) by developing innovative clinical programmes that employ harm reduction, and thereby (3) changing the standard of care to include routine use of these evidence-based (but often misunderstood) approaches in their practices. We argue that through promotion of harm-reduction goals and methods, clinicians have unique opportunities to improve the health outcomes of vulnerable populations.
KeywordsAddiction Substance use Harm reduction Structural interventions Drug policy
- Ali, R., M. Auriacombe, M. Casas, et al. 1999. Report of The External Panel on the Evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. Ginebra: Organización Mundial de la Salud (Substance Abuse Department). http://www.ewi-psy.fu-berlin.de/einrichtungen/arbeitsbereiche/ppg/media/publikationen/dk-pdfs/Report_of_the_External_Panel_on_the_Evaluation_of_the_Swiss_Scientific_Studies_of_Medically_Prescribed_Narcotics_to_Drug_Addicts__1999_.pdf.
- Anderson, K. 2014. Addiction treatment: Who gets it and who needs it? Substance, October 24. http://www.substance.com/addiction-treatment-who-gets-it-and-who-needs-it/14466/. Accessed October 24, 2014.
- Berridge, V., and G. Edwards. 1987. Opium and the people: Opiate use in nineteenth-century England. New Haven, CT: Yale University Press.Google Scholar
- Coffin, P. 2008. Overdose: A major cause of preventable death in Central and Eastern Europe and Central Asia: Recommendations and overview of the situation in Latvia, Kyrgyzstan, Romania, Russia, Tajikistan. Vilnius: Eurasian Harm Reduction Network (EHRN).Google Scholar
- Cornish, R., J. Macleod, J. Strang, P. Vickerman, and M. Hickman. 2010. Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK General Practice Research Database. British Medical Journal 341: c5475. doi: 10.1136/bmj.c5475.CrossRefPubMedPubMedCentralGoogle Scholar
- Degenhardt, L., B. Larance, B. Mathers, et al. 2008. Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV. Edited by the National Drug and Alcohol Research Centre. Sydney: University of New South Wales. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Pharmaceutical%20opioid%20injection.pdf.
- Drucker, E. 2015. Prisons: From punishment to public health. In Oxford textbook of global public health, 6th ed., edited by R. Detels, M. Gulliford, Q.A. Karim, and C.C. Tan, 1445–1462. Oxford: Oxford University Press.Google Scholar
- Drucker, E. 2014. Mass incarceration as a global policy dilemma: Limiting disaster and evaluating alternatives. In Ending the drug wars: Report of the London School of Economics Expert Group on Drug Policy, edited by J. Collins, 61–69. London: LSE Expert Group on the Economics of Drug Policy.Google Scholar
- Drucker, E. 2013. A plague of prisons: The epidemiology of mass incarceration in America. New York: The New Press.Google Scholar
- Drucker, E., R.G. Newman, E. Nadelmann, et al. 2011. Harm reduction: New drug policies and practices. In Substance abuse: A comprehensive textbook, edited by P. Ruiz and E. Strain, 754–776. New York: Williams and Wilkins.Google Scholar
- European Monitoring Centre for Drugs and Drug Addiction. 2011. Annual report: The state of the drugs problem in Europe. Portugal: European Monitoring Centre for Drugs and Drug Addiction. doi: 10.2810/44330 and http://www.emcdda.europa.eu/attachements.cfm/att_143743_EN_EMCDDA_AR2011_EN.pdf.
- Hedrich, D., T. Kerr, and F. Dubois-Arber. 2010. Drug consumption facilities in Europe and beyond. In EMCDDA monographs—harm reduction: Evidence, impacts and challenges, edited by T. Rhodes and D. Hedrich, 305–332. Portugal: European Monitoring Centre for Drugs and Drug Addiction.Google Scholar
- Marshall, B.D.L., M,J. Milloy, E. Wood, J.S.G. Montaner, and T. Kerr. 2011. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: A retrospective population-based study. The Lancet 377(9775): 1429–1437.Google Scholar
- Musto, D.F. 1999. The American disease: Origins of narcotic control, 3rd ed. New York: Oxford University Press.Google Scholar
- National Institutes of Health. 1997. Effective medical treatment of opiate addiction. NIH Consensus Statement 15(6): 1–38.Google Scholar
- O’Hare, P.A., R. Newcombe, A. Matthews, E. Buning, and E. Drucker. 1992. The reduction of drug-related harm. London: Routledge.Google Scholar
- Ruiz, P., E.C. Strain, and J.H. Lowinson. 2011. Lowinson and Ruiz’s substance abuse: A comprehensive textbook, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.Google Scholar
- Stone, K. 2014. The global state of harm reduction 2014. London: Harm Reduction International.Google Scholar
- Strang, J., V. Manning, S, Mayet, et al. 2008. Overdose training and take-home naloxone for opiate users: Prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 103(10): 1648–1657.Google Scholar
- Tatarsky, A. 2002. Harm reduction psychotherapy: A new treatment for drug and alcohol problems. Northvale, NJ: Jason Aronson.Google Scholar
- United Nations Office on Drugs and Crime. 2012. World drug report 2012. New York: United Nations Publications.Google Scholar
- Uchtenhage, A., F. Gutzwiller, and A. Dobler-Mikola, eds. 1998. Medical prescription of narcotics research programme: Final report of the principal investigators. Zurich: Institute for Social and Preventive Medicine at the University of Zurich.Google Scholar
- Van Beek, I. 2004. In the eye of the needle: Diary of a medically supervised injecting centre. Crows Nest, NSW: Allen & Unwin.Google Scholar
- Waldorf, D., M. Orlick, and C. Reinarman. 1974. Morphine maintenance: The Shreveport clinic 1919–1923. Washington, DC: Drug Abuse Council, Inc.Google Scholar
- World Health Organization. 2010. Priority interventions: HIV/AIDS prevention, treatment and care in the health sector. Geneva: World Health Organization, NLM classification: WC 503.6.Google Scholar